Table 2.
Multivariate analysis of prognostic factors in patients with advanced gastric cancer
| Clinicopathological feature | Multivariate analysis DFS | Multivariate analysis DSS | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p value | HR | 95% CI | p value | |
| Age (years) | ||||||
| ≤ 60 | 1 | 1 | ||||
| > 60 | 1.61 | 1.10–2.35 | 0.014 | 1.61 | 1.06–2.42 | 0.024 |
| PLR | ||||||
| < 154 | 1 | 1 | ||||
| ≥ 154 | 2.00 | 1.40–2.84 | < 0.001 | 2.09 | 1.43–3.04 | < 0.001 |
| TNM | ||||||
| II | 1 | 1 | ||||
| III | 4.46 | 2.51–7.91 | < 0.001 | 5.94 | 3.01–11.74 | < 0.001 |
| Chemotherapy | ||||||
| No | 1 | 1 | ||||
| Yes | 0.70 | 0.48–1.04 | 0.074 | 0.66 | 0.45–0.99 | 0.043 |
DFS Disease-free survival, DSS Disease-specific survival, HR Hazard ratios, CI Confidence interval, PLR Platelet-lymphocyte ratio